News Highlights: Top Company News of the Day
December 05 2021 - 9:30PM
Dow Jones News
Kohl's Urged to Consider Sale by Activist Investor
Activist Engine Capital sent a letter also pressing the
department-store chain to consider a separation of its e-commerce
business.
Nvidia's Deal Setback Eased by Soaring Chip Demand
The FTC has sued to block Nvidia's proposed takeover of Arm
Holdings. But analysts say exploding growth in semiconductor demand
is expected to ease the setback facing the chip maker if it can't
complete the deal.
Cruise Pricing Risks Sailing Off the Deep End
Cruise pricing has never been a better deal for consumers in
some cases. But cruise companies can't afford for that dynamic to
last.
CNN President Jeff Zucker Protected Chris Cuomo. Then Came a U-Turn.
The network boss fired the star anchor on Saturday, leaving a
hole in the channel's prime-time lineup.
California Dairy Farmers Struggle to Stay in the 'Got Milk' State
Recurring droughts add to challenges in the nation's top milk
producer, causing farmers to move, close or turn to growing crops.
"We're scared to death we'll have one more dry year."
Spotify Removes Some Comedians' Work From Streaming Service
A push for royalty payments on comedic material has sidelined
the work of Jim Gaffigan, John Mulaney and hundreds of other
comedians on Spotify.
Noodles Restaurant Chain Bets on Costlier Cheesy Pasta
Colorado-based Noodles & Co. and other U.S. restaurant
chains are weighing consumers' willingness to spend more on food as
prices for goods rise.
Boral to Sell North American Fly Ash Unit
Boral Ltd. will sell its North American fly ash business for
$755 million to Eco Material Technologies Inc., as part of its
strategic overhaul to refocus on Australia's construction materials
sector.
U.K. Digital-Health Startup Vinehealth Raises Seed Financing
Vinehealth Digital uses its technology to help drugmakers better
understand cancer patients' experience with their medications.
Lilly's Covid-19 Antibody Treatment Authorized for Use in Children
The FDA's authorization expands the drug's use to fight Covid-19
to people under the age of 12.
(END) Dow Jones Newswires
December 05, 2021 21:15 ET (02:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.